OMCL
Omnicell, Inc.

708
Mkt Cap
$1.43B
Volume
15,490.00
52W High
$55.75
52W Low
$22.66
PE Ratio
63.04
OMCL Fundamentals
Price
$30.98
Prev Close
$31.10
Open
$31.22
50D MA
$31.42
Beta
1.16
Avg. Volume
503,100.00
EPS (Annual)
$0.2709
P/B
1.14
Rev/Employee
$303,062.13
Loading...
Loading...
News
all
press releases
Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 43.7% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Earnings Preview: Omnicell (OMCL) Q3 Earnings Expected to Decline
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·4d ago
News Placeholder
Are Investors Undervaluing Omnicell (OMCL) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·4d ago
News Placeholder
10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last?
10x Genomics (TXG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·6d ago
News Placeholder
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks·10d ago
News Placeholder
NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings
NVDA and PLTR drive AI integration across healthcare, fueling optimism for Omnicell and Tempus AI's Q3 performance.
Zacks·13d ago
News Placeholder
Is Omnicell (OMCL) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·20d ago
News Placeholder
Reasons to Add Omnicell Stock to Your Portfolio Right Now
OMCL's expanding SaaS portfolio, overseas growth plans, and solid balance sheet position it for sustained momentum despite rising competition.
Zacks·20d ago
News Placeholder
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks·26d ago
News Placeholder
BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience
BDX partners with Henry Ford Health to deploy BD Rowa Vmax robots, aiming to streamline 24/7 pharmacy access in Michigan.
Zacks·26d ago

Latest OMCL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.